Gujarat Narmada Valley Fertilizers & Chemicals Ltd
Gujarat Narmada Valley Fertilizers & Chemicals Limited (GNFC), is a joint sector enterprise promoted by the Gujarat State Investments Limited (GSIL), a Government of Gujarat undertaking, and the Gujarat State Fertilizers & Chemicals Ltd.(GSFC). The company was set up in Bharuch in 1976 while its manufacturing and marketing operations were started in 1982. The company operates businesses mainly in the Industrial Chemicals, Fertilizers apart from the small presence of IT services. In the chemical segment, it has a product portfolio of various bulk chemicals that are used in industries for manufacturing various specialty chemicals as well as end products.
- Market Cap ₹ 7,387 Cr.
- Current Price ₹ 503
- High / Low ₹ 616 / 365
- Stock P/E 9.14
- Book Value ₹ 620
- Dividend Yield 3.58 %
- ROCE 12.0 %
- ROE 9.13 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.81 times its book value
- Stock is providing a good dividend yield of 3.58%.
- Company has been maintaining a healthy dividend payout of 43.7%
Cons
- The company has delivered a poor sales growth of 8.67% over past five years.
- Company has a low return on equity of 7.32% over last 3 years.
- Earnings include an other income of Rs.499 Cr.
- Working capital days have increased from 102 days to 188 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4,642 | 4,552 | 4,589 | 5,837 | 5,896 | 5,162 | 5,129 | 8,642 | 10,227 | 7,930 | 7,892 | 7,773 | |
| 4,662 | 3,989 | 4,228 | 4,445 | 5,022 | 4,621 | 4,125 | 6,259 | 8,348 | 7,428 | 7,277 | 6,894 | |
| Operating Profit | -21 | 563 | 361 | 1,392 | 874 | 542 | 1,003 | 2,384 | 1,879 | 502 | 615 | 879 |
| OPM % | -0% | 12% | 8% | 24% | 15% | 10% | 20% | 28% | 18% | 6% | 8% | 11% |
| 52 | 252 | 809 | 140 | 215 | 153 | 237 | 209 | 361 | 469 | 501 | 499 | |
| Interest | 274 | 297 | 203 | 100 | 6 | 5 | 20 | 3 | 5 | 13 | 23 | 6 |
| Depreciation | 209 | 251 | 251 | 270 | 263 | 264 | 272 | 292 | 303 | 308 | 303 | 307 |
| Profit before tax | -452 | 268 | 715 | 1,162 | 819 | 425 | 948 | 2,298 | 1,932 | 651 | 790 | 1,065 |
| Tax % | 0% | 35% | 27% | 32% | 10% | -17% | 27% | 26% | 24% | 26% | 26% | 25% |
| -443 | 180 | 529 | 795 | 750 | 508 | 697 | 1,710 | 1,472 | 497 | 598 | 808 | |
| EPS in Rs | -28.50 | 11.57 | 34.02 | 51.15 | 48.24 | 32.69 | 44.84 | 110.05 | 94.68 | 33.83 | 40.68 | 54.99 |
| Dividend Payout % | 0% | 17% | 15% | 15% | 15% | 15% | 18% | 9% | 32% | 49% | 44% | 38% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 9% |
| 3 Years: | -9% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 3% |
| 3 Years: | -18% |
| TTM: | 35% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 7% |
| 3 Years: | -6% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 155 | 147 | 147 | 147 |
| Reserves | 2,364 | 3,168 | 3,700 | 4,362 | 4,909 | 5,144 | 5,913 | 7,835 | 8,950 | 8,162 | 8,429 | 8,968 |
| 3,844 | 3,101 | 1,959 | 303 | 208 | 860 | 4 | 2 | 2 | 3 | 106 | 6 | |
| 2,164 | 2,130 | 2,142 | 2,411 | 2,337 | 2,261 | 2,321 | 2,764 | 2,613 | 2,405 | 2,366 | 2,238 | |
| Total Liabilities | 8,527 | 8,555 | 7,956 | 7,231 | 7,609 | 8,421 | 8,394 | 10,755 | 11,720 | 10,717 | 11,047 | 11,359 |
| 4,468 | 4,367 | 4,442 | 4,161 | 3,959 | 3,810 | 3,720 | 3,578 | 3,381 | 3,238 | 3,094 | 2,881 | |
| CWIP | 13 | 9 | 14 | 14 | 25 | 82 | 161 | 138 | 187 | 289 | 382 | 900 |
| Investments | 184 | 775 | 816 | 785 | 799 | 673 | 938 | 1,313 | 3,205 | 3,030 | 2,304 | 1,692 |
| 3,861 | 3,404 | 2,683 | 2,271 | 2,826 | 3,856 | 3,575 | 5,727 | 4,946 | 4,160 | 5,268 | 5,886 | |
| Total Assets | 8,527 | 8,555 | 7,956 | 7,231 | 7,609 | 8,421 | 8,394 | 10,755 | 11,720 | 10,717 | 11,047 | 11,359 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 490 | 996 | 1,445 | 1,819 | 701 | 286 | 1,884 | 1,967 | 1,373 | 31 | 605 | 654 | |
| -284 | 36 | -53 | 49 | -310 | -901 | -856 | -1,899 | -1,229 | 1,235 | -466 | -231 | |
| -363 | -1,037 | -1,073 | -1,400 | -185 | 546 | -934 | -130 | -160 | -1,281 | -262 | -269 | |
| Net Cash Flow | -156 | -5 | 320 | 468 | 206 | -69 | 95 | -62 | -16 | -14 | -123 | 154 |
| Free Cash Flow | 207 | 931 | 1,358 | 1,850 | 603 | 155 | 1,669 | 1,829 | 1,202 | -218 | 154 | 108 |
| CFO/OP | -2,423% | 179% | 422% | 146% | 93% | 62% | 210% | 109% | 104% | 49% | 128% | 111% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 107 | 119 | 88 | 70 | 77 | 100 | 36 | 26 | 13 | 29 | 20 | 30 |
| Inventory Days | 98 | 107 | 110 | 98 | 106 | 125 | 129 | 91 | 84 | 94 | 105 | 92 |
| Days Payable | 39 | 40 | 57 | 61 | 50 | 68 | 63 | 59 | 42 | 42 | 40 | 41 |
| Cash Conversion Cycle | 166 | 186 | 142 | 107 | 132 | 156 | 103 | 58 | 55 | 81 | 84 | 81 |
| Working Capital Days | 9 | 8 | 27 | 57 | 76 | 117 | 68 | 97 | 46 | 58 | 61 | 188 |
| ROCE % | 9% | 10% | 24% | 16% | 8% | 16% | 33% | 23% | 8% | 10% | 12% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ammonia Production MT ・Standalone data |
|
||||||||||
| Formic Acid Production MT ・Standalone data |
|||||||||||
| Urea Production MT ・Standalone data |
|||||||||||
| Weak Nitric Acid (WNA) Production MT ・Standalone data |
|||||||||||
| Acetic Acid Production MT ・Standalone data |
|||||||||||
| TDI Total Production MT ・Standalone data |
|||||||||||
| AN Melt / ANP Production MT ・Standalone data |
|||||||||||
| Concentrated Nitric Acid (CNA) Production MT ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Closure of Trading Window 9h
-
Board Meeting Intimation for Consideration Of Unaudited Financial
Results For The First Quarter Ended On June 30, 2026.
9h - Board meets August 5, 2026 to approve Q1 FY27 results; trading window remains closed until 48 hours after announcement.
-
Communication To Shareholder - Intimation On Tax Deduction On Dividend
11 Jul - GNFC explains TDS process for ₹21 dividend recommended for FY26, with documents due by August 15, 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
2 Jul - Submitted Regulation 74(5) depository certificate for quarter ended June 30, 2026.
- Closure of Trading Window 25 Jun
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from nse
Concalls
-
May 2026TranscriptPPTREC
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Feb 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
May 2021TranscriptPPT
-
Mar 2021TranscriptPPT
-
Feb 2018TranscriptPPT
-
Nov 2017TranscriptPPT
-
Aug 2017TranscriptPPT
Business Segments
1) Chemicals (60% in H1 FY25 vs 70% in FY22): [1] [2] The company produces Methanol, Formic Acid, Acetic Acid, Toluene Di- Isocyanate (TDI), Technical Grade Urea (TGU), Weak Nitric Acid, Concentrated Nitric Acid, Ethyl Acetate, and Ammonium Nitrate. The segment revenue declined 29% between FY22 and FY24, driven by lower realizations across all the products. [3] [4]